Alexian Village Of Tennessee | |
671 Alexian Way, Signal Mountain, Tennessee 37377 | |
(423) 886-0100 | |
Name | Alexian Village Of Tennessee |
---|---|
Location | 671 Alexian Way, Signal Mountain, Tennessee |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 114 |
Occupancy Rate | 70.79% |
Medicare ID (CCN) | 445123 |
Legal Business Name | Alexian Brothers Of Signal Mtn Tenn Inc |
Ownership Type | Non Profit - Church Related |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
News outlets report on the details of the ad campaign, which is being paid for by Crossroads GPS - and also provide fact checking regarding some of its assertions.
Small cell lung cancer is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy. The research group headed by Gerhard Hamilton, University Department of Surgery at MedUni Vienna, has now managed to identify the reason for this chemoresistance.
A specific genetic variation may be tied to an increased risk for severe premenstrual depression, scientists at the University of North Carolina at Chapel Hill and the National Institute of Mental Health have found.
Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 9.36 | 14.46 |
Percentage of long-stay residents who lose too much weight | 14.14 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.87 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 6.18 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.43 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.63 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.98 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 15.09 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 85.71 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 4.74 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 18.85 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.17 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.58 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.75 | 95.98 |
Percentage of short-stay residents who made improvements in function | 83.95 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.97 | 82.93 |
News Archive
News outlets report on the details of the ad campaign, which is being paid for by Crossroads GPS - and also provide fact checking regarding some of its assertions.
Small cell lung cancer is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy. The research group headed by Gerhard Hamilton, University Department of Surgery at MedUni Vienna, has now managed to identify the reason for this chemoresistance.
A specific genetic variation may be tied to an increased risk for severe premenstrual depression, scientists at the University of North Carolina at Chapel Hill and the National Institute of Mental Health have found.
Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).
› Verified 6 days ago
Alexian Village Of Tennessee Location: 671 Alexian Way, Signal Mountain, Tennessee 37377 Phone: (423) 886-0100 |